Last update:

Medications news

Medications

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer's disease.

Medications

Study finds sex bias in emergency department pain management

A new study reveals a significant sex bias in pain management at emergency departments, showing that female patients are consistently less likely to receive pain medication prescriptions compared to male patients with similar ...

Medications

A new drug could turn back the clock on multiple sclerosis

Multiple sclerosis (MS) degrades the protective insulation around nerve cells, leaving their axons, which carry electrical impulses, exposed like bare wires. This can cause devastating problems with movement, balance and ...

Medications

Psoriasis drug shows promise for treating childhood diabetes

A drug that is currently used for the treatment of psoriasis has been found to be effective in treating the early stages of type-1 diabetes in children and adolescents, finds a new clinical trial led by Cardiff University.

Medications

New drug candidate blocks resistance to cancer therapies

A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance. The design and preclinical evaluation ...

Medications

European medicines watchdog rejects new Alzheimer's drug

Europe's medicines watchdog on Friday rejected a marketing request for a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits.

Medications

Study identifies first drug therapy for sleep apnea

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study demonstrating the potential of tirzepatide, known to manage type 2 diabetes, as the ...

Medications

Popular diabetes drugs may reduce the risk of dementia

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet published in the journal eClinicalMedicine.

Medications

New study establishes best practices for supervised psilocybin

Last year, Oregon became the first state in the nation to provide state-regulated access to supervised services involving mind-altering magic mushrooms—raising the likelihood of introducing psilocybin to many Oregonians ...

Medications

Researchers studying MDMA-assisted treatment for PTSD

Therapists have discovered a variety of effective treatments for patients with post-traumatic stress disorder: Talk therapy, narrative writing, medication and a system that involves discussing painful experiences while focusing ...

Medications

A simple change to save thousands of patients with sepsis

Changing the way antibiotics are given to adult patients with sepsis will save thousands of lives a year globally, according to research by The University of Queensland and The George Institute for Global Health.